Arcus Biosciences (RCUS) Payables (2017 - 2025)
Historic Payables for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to $42.0 million.
- Arcus Biosciences' Payables rose 22307.69% to $42.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.0 million, marking a year-over-year increase of 22307.69%. This contributed to the annual value of $18.0 million for FY2024, which is 588.24% up from last year.
- Per Arcus Biosciences' latest filing, its Payables stood at $42.0 million for Q3 2025, which was up 22307.69% from $29.0 million recorded in Q2 2025.
- Arcus Biosciences' Payables' 5-year high stood at $42.0 million during Q3 2025, with a 5-year trough of $10.0 million in Q4 2021.
- Its 5-year average for Payables is $19.2 million, with a median of $17.0 million in 2023.
- In the last 5 years, Arcus Biosciences' Payables skyrocketed by 91170.65% in 2021 and then crashed by 4541.48% in 2023.
- Arcus Biosciences' Payables (Quarter) stood at $10.0 million in 2021, then surged by 100.0% to $20.0 million in 2022, then decreased by 15.0% to $17.0 million in 2023, then increased by 5.88% to $18.0 million in 2024, then surged by 133.33% to $42.0 million in 2025.
- Its last three reported values are $42.0 million in Q3 2025, $29.0 million for Q2 2025, and $22.0 million during Q1 2025.